Delamanid-containing regimens over 24 weeks for the treatment of multidrug-resistant/rifampicin-resistant tuberculosis: preliminary results from a single center in a multicenter, prospective, observational study

BackgroundSingle center preliminary results from a multicenter, prospective, observational study whose aims were to investigate the efficacy and safety of 24-week delamanid-containing regimens in Chinese multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) patients.MethodsThe study incl...

Полное описание

Библиографические подробности

Главные авторы:	Fuping Yang, Mingdan Yin, Xingmei Jiang, Xing Zhao, Xuemei An, Yan Liu, Yijia Yuan
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2025-09-01
Серии:	Frontiers in Medicine
Предметы:	multidrug-resistant tuberculosis rifampicin-resistant tuberculosis delamanid optimal background regimen sputum culture conversion
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1631030/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!